Acta Cytologica

Novel Insights from Clinical Practice

Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors

Matsushita M.a,b · Kuwamoto S.b,c

Author affiliations

aDepartment of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University, Yonago, Japan
bDivision of Molecular Pathology, Faculty of Medicine, Tottori University, Yonago, Japan
cDepartment of Pathology, Tottori University Hospital, Yonago, Japan

Related Articles for ""

Acta Cytologica 2018;62:456–462

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Novel Insights from Clinical Practice

Received: July 22, 2018
Accepted: August 29, 2018
Published online: October 04, 2018
Issue release date: September - October

Number of Print Pages: 7
Number of Figures: 2
Number of Tables: 1

ISSN: 0001-5547 (Print)
eISSN: 1938-2650 (Online)

For additional information: https://www.karger.com/ACY

Abstract

Background: SMARCA4-deficient thoracic sarcoma is a recently proposed entity of soft tissue tumors associated with an extremely poor prognosis. Its cytologic features have not been well described in the literature yet. Case: A woman in her early 30s who presented with chest pain was found to have a tumor in the right chest wall. Cytologic smears revealed numerous atypical round-to-polygonal cells appearing singly or in loosely cohesive clusters. These cells had a well-defined cell border, scant-to-moderate cytoplasm, and enlarged vesicular nuclei with prominent nucleoli. In addition, some cells with eosinophilic globular intracytoplasmic inclusions and eccentrically located nuclei, consistent with rhabdoid cells, were observed. Immunocytochemically, the cells were at least focally positive for cytokeratin CAM5.2 and CD34 and showed a significantly reduced BRG1/SMARCA4 expression. The diagnosis was confirmed by histological, immunohistochemical, and genetic analysis of a metastatic lesion to the left axillary lymph node. Conclusion: Although the cytologic features of SMARCA4-deficient thoracic sarcoma are not fully unique, they are sufficiently characteristic to suspect this tumor in cases of supporting clinical and radiological features, which may promote additional immunological or molecular testing to establish a definitive diagnosis.

© 2018 S. Karger AG, Basel




Related Articles:


References

  1. Le Loarer F, Watson S, Pierron G, de Montpreville VT, Ballet S, Firmin N, et al. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Nat Genet. 2015 Oct;47(10):1200–5.
  2. Yoshida A, Kobayashi E, Kubo T, Kodaira M, Motoi T, Motoi N, et al. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities. Mod Pathol. 2017 Jun;30(6):797–809.
  3. Sauter JL, Graham RP, Larsen BT, Jenkins SM, Roden AC, Boland JM. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior. Mod Pathol. 2017 Oct;30(10):1422–32.
  4. Kuwamoto S, Matsushita M, Takeda K, Tanaka N, Endo Y, Yamasaki A, et al. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources. Hum Pathol. 2017 Dec;70:92–7.
  5. Fuller CE. All things rhabdoid and SMARC: an enigmatic exploration with Dr. Louis P. Dehner. Semin Diagn Pathol. 2016 Nov;33(6):427–40.
  6. Schaefer IM, Agaimy A, Fletcher CD, Hornick JL. Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas. Mod Pathol. 2017 Apr;30(4):539–48.
  7. Shah VI, Ramalingam P, McCluggage WG. CD34 expression in undifferentiated endometrial carcinoma. Histopathology. 2016 Nov;69(5):894–7.
  8. González-Peramato P, Jiménez-Heffernan JA, Cuevas J. Fine-needle aspiration cytology of “proximal-type” epithelioid sarcoma. Diagn Cytopathol. 2001 Aug;25(2):122–5.
  9. Ikeda K, Tate G, Suzuki T, Mitsuya T. Fine needle aspiration cytology of primary proximal-type epithelioid sarcoma of the perineum: a case report. Acta Cytol. 2005 May-Jun;49(3):314–8.
  10. Pendse AA, Dodd LG. Fine-needle-aspiration cytology of a proximal type epithelioid sarcoma: A case report. Diagn Cytopathol. 2015 Oct;43(10):859–62.
  11. Rekhi B, Singh N. Spectrum of cytopathologic features of epithelioid sarcoma in a series of 7 uncommon cases with immunohistochemical results, including loss of INI1/SMARCB1 in two test cases. Diagn Cytopathol. 2016 Jul;44(7):636–42.
  12. Barroca HM, Costa MJ, Carvalho JL. Cytologic profile of rhabdoid tumor of the kidney. A report of 3 cases. Acta Cytol. 2003 Nov-Dec;47(6):1055–8.
  13. Cocker RS, Sharaan M, Wasserman P. Malignant rhabdoid tumor of the kidney in a child: report of a case with recurrence in the contralateral kidney. Acta Cytol. 2004 Nov-Dec;48(6):836–42.
  14. Shet T, Viswanathan S. The cytological diagnosis of paediatric renal tumours. J Clin Pathol. 2009 Nov;62(11):961–9.
  15. Thomson TA, Klijanienko J, Couturier J, Brisse H, Pierron G, Freneaux P, et al. Fine-needle aspiration of renal and extrarenal rhabdoid tumors: the experience of the Institut Curie regarding 20 tumors in 13 patients. Cancer Cytopathol. 2011 Feb;119(1):49–57.
  16. Dharan M. Intraoperative cytology of small cell carcinoma of the ovary with hypercalcemia. A case report. Acta Cytol. 1993 Jan-Feb;37(1):61–6.
    External Resources
  17. Selvaggi SM. Small-cell carcinoma of the ovary in peritoneal fluid. Diagn Cytopathol. 1994;11(3):266–70.
  18. Shintaku M, Wada K, Wakasa T, Mise Y. Small cell carcinoma of the ovary of the hypercalcemic type, intraoperative cytological findings of a case. J Jpn Soc Clin Cytol. 2015;54(2):164–9.
    External Resources
  19. Trichia HJ, Tziakou P, Papatheodorou DC, Lekka J. Cytological features of the large cell variant of small cell ovarian carcinoma in young patients with hypercalcemia: histological findings and review of the literature. Acta Cytol. 2017;61(6):462–8.
  20. Laé M, Bourgoin R, Cornelis F, Klijanienko J. Cytological features of small cell carcinoma of the ovary-hypercalcemic type/malignant ovarian rhabdoid tumor in ascitic fluid. Diagn Cytopathol. 2018 Apr;46(4):365–6.
  21. Hasegawa T, Matsuno Y, Shimoda T, Umeda T, Yokoyama R, Hirohashi S. Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases. Mod Pathol. 2001 Jul;14(7):655–63.

Article / Publication Details

First-Page Preview
Abstract of Novel Insights from Clinical Practice

Received: July 22, 2018
Accepted: August 29, 2018
Published online: October 04, 2018
Issue release date: September - October

Number of Print Pages: 7
Number of Figures: 2
Number of Tables: 1

ISSN: 0001-5547 (Print)
eISSN: 1938-2650 (Online)

For additional information: https://www.karger.com/ACY


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP